From U.S. clinical labs to Europe’s IVD market and fast-growing Asia-Pacific, lab testing outcomes depend on regional demand, reimbursement, and the mix of lab-based versus point-of-care services. The global clinical laboratory services market is projected to reach USD 421.5 billion by 2032, driven by steady growth and expanding use cases. Across the page, you’ll see how regional market forecasts, major players’ shares, and faster technologies—from AI-assisted diagnostics to lab-on-a-chip—connect to capacity and revenue trends.
Key Takeaways
- Global clinical laboratory services market expected to reach USD 421.5 billion by 2032 at a CAGR of 5.9%
- U.S. clinical labs industry projected to grow 2.8% annually to 2028
- Europe's IVD market forecasted to grow at 4.5% CAGR through 2030
- Quest Diagnostics held 25% market share in U.S. clinical lab testing in 2023
- LabCorp (Laboratory Corporation of America) commanded 22% U.S. market share in 2023 diagnostics
- Sonic Healthcare dominated 35% of Australia's pathology market in 2023
- The global clinical laboratory services market was valued at USD 250.92 billion in 2022 and is projected to grow at a CAGR of 5.8% from 2023 to 2030
- In the United States, the clinical laboratories industry generated revenue of $92.4 billion in 2023
- Europe's in vitro diagnostics market reached €28.5 billion in 2022
- U.S. accounts for 40% of global clinical lab services market in 2023
- North America held 38.5% share of IVD market worldwide in 2022
- Europe represented 28% of global pathology services market in 2023
- NGS adoption in labs increased by 45% from 2020 to 2023 globally
- AI integration in lab diagnostics improved accuracy by 30% in 2023 studies
- Digital pathology systems grew 18% in installations worldwide 2023
Global lab testing is set for steady expansion through 2030, driven by rising diagnostics demand and faster technologies.
Related reading
01 · Category
Growth Rates30 stats
01
Global clinical laboratory services market expected to reach USD 421.5 billion by 2032 at a CAGR of 5.9%
02
U.S. clinical labs industry projected to grow 2.8% annually to 2028
03
Europe's IVD market forecasted to grow at 4.5% CAGR through 2030
04
U.S. diagnostic labs market to expand at 6.2% CAGR from 2024-2029
05
Global pathology services market to grow at 7.1% CAGR to 2030
06
India's lab testing market projected to grow 15% annually to 2028
07
China's clinical testing sector expected 12% CAGR to 2030
08
Molecular diagnostics market to grow at 10.5% CAGR globally to 2028
09
U.S. anatomic pathology market forecasted 5.8% CAGR to 2032
10
Global lab automation market to expand at 7.2% CAGR to 2030
11
Clinical chemistry testing projected 6.1% CAGR worldwide to 2030
12
Brazil's clinical labs market to grow 8.3% annually to 2027
13
Australia's pathology market expected 3.5% CAGR through 2029
14
Japan's lab testing market to grow at 4.2% CAGR to 2030
15
Global POCT market forecasted 9.8% CAGR to 2029
16
U.S. microbiology testing to expand at 5.4% CAGR to 2030
17
Immunoassay market projected 6.7% CAGR globally to 2030
18
Canada's clinical labs expected 4.1% annual growth to 2028
19
South Korea's IVD market to grow 8.9% CAGR to 2030
20
Hematology testing market forecasted 7.3% CAGR worldwide to 2028
21
Germany's clinical labs to grow at 3.9% CAGR through 2030
22
Global cytogenetic market expected 9.2% CAGR to 2032
23
U.K. pathology labs projected 4.6% growth annually to 2029
24
France's medical labs market to expand at 5.2% CAGR to 2030
25
Italy's clinical analysis expected 4.8% CAGR through 2028
26
Spain's lab services forecasted 6.1% annual growth to 2027
27
Mexico's clinical labs to grow 10.5% CAGR to 2030
28
Global NGS lab testing projected 15.4% CAGR to 2030
29
U.S. esoteric testing market expected 7.8% CAGR to 2029
30
Urinalysis market for labs to grow at 5.9% CAGR globally to 2028
Interpretation
Growth Rates Interpretation
For the Growth Rates category, the standout trend is that while global clinical lab services are rising steadily at a 5.9% CAGR to USD 421.5 billion by 2032, India’s lab testing market is accelerating far faster at 15% annually to 2028, highlighting how regional growth momentum is outpacing the global pace.
02 · Category
Key Players29 stats
01
Quest Diagnostics held 25% market share in U.S. clinical lab testing in 2023
02
LabCorp (Laboratory Corporation of America) commanded 22% U.S. market share in 2023 diagnostics
03
Sonic Healthcare dominated 35% of Australia's pathology market in 2023
04
Synlab Group led Europe's clinical lab services with 15% share in 2022
05
Bio-Reference Laboratories captured 8% of U.S. esoteric testing market in 2023
06
ARUP Laboratories held 12% share in U.S. reference lab testing in 2023
07
Mayo Clinic Laboratories accounted for 10% of advanced diagnostics in U.S. 2023
08
Unilabs controlled 20% of Nordic clinical lab market in 2023
09
Cerba Healthcare had 18% share in French lab testing in 2023
10
Fresenius Helios labs led German hospital-based testing with 14% share 2023
11
Thyrocare dominated 25% of India's organized lab testing market in 2023
12
Metropolis Healthcare held 15% share in Indian diagnostics in 2023
13
Dr. Lal PathLabs captured 20% of India's metro lab market in 2023
14
Kindred Healthcare influenced 10% U.S. post-acute lab testing in 2023
15
Spectra Laboratories led U.S. dialysis lab testing with 30% share 2023
16
NeoGenomics held 22% of U.S. oncology lab testing market in 2023
17
Myriad Genetics commanded 18% share in genetic testing labs U.S. 2023
18
Invitae captured 12% of U.S. clinical genomics lab market in 2023
19
Exact Sciences held 25% share in U.S. cancer screening labs 2023
20
Guardant Health led liquid biopsy lab testing with 20% U.S. share 2023
21
Tempus AI influenced 15% of precision oncology lab data in 2023 U.S.
22
Caris Life Sciences held 10% share in molecular profiling labs U.S. 2023
23
Foundation Medicine (Roche) captured 28% U.S. companion diagnostics lab share 2023
24
PathGroup accounted for 9% of U.S. anatomic pathology labs in 2023
25
Alverno Laboratories held 7% share in Midwest U.S. lab testing 2023
26
LabCorp's revenue from clinical lab services was $11.2 billion in 2023
27
Quest Diagnostics reported $9.3 billion in lab testing revenue 2023
28
Sonic Healthcare's global lab revenue reached AUD 6.8 billion in 2023
29
Synlab's European lab services generated €2.1 billion revenue in 2023
Interpretation
Key Players Interpretation
In the key players landscape, the biggest firms are concentrating substantial U.S. and regional share, with Quest Diagnostics leading at 25% of the U.S. market, LabCorp close behind at 22%, and even in Australia Sonic Healthcare commanding 35% in 2023.
03 · Category
Market Size30 stats
01
The global clinical laboratory services market was valued at USD 250.92 billion in 2022 and is projected to grow at a CAGR of 5.8% from 2023 to 2030
02
In the United States, the clinical laboratories industry generated revenue of $92.4 billion in 2023
03
Europe's in vitro diagnostics market reached €28.5 billion in 2022
04
The U.S. diagnostic labs sector had a market size of $85.6 billion as of 2023
05
Global pathology services market valued at $38.4 billion in 2023
06
India's medical laboratory testing market was worth INR 45,000 crore in FY2023
07
China’s clinical testing market size hit CNY 1,200 billion in 2023
08
The molecular diagnostics segment of lab testing reached $12.5 billion globally in 2022
09
U.S. anatomic pathology market size was $25.3 billion in 2023
10
Global lab automation market valued at $5.2 billion in 2023
11
The clinical chemistry testing market stood at $12.1 billion worldwide in 2022
12
Brazil's clinical analysis labs market generated BRL 35 billion in 2023
13
Australia's pathology services market was AUD 12.5 billion in 2023
14
Japan's diagnostic imaging and lab testing market hit JPY 2.5 trillion in 2023
15
The global POCT market for labs was $38.9 billion in 2023
16
U.S. microbiology testing market size reached $6.8 billion in 2023
17
Global immunoassay market valued at $28.7 billion in 2022
18
Canada's clinical labs industry revenue was CAD 8.2 billion in 2023
19
South Korea's in vitro diagnostics market was KRW 4.5 trillion in 2023
20
The hematology testing market globally was $11.2 billion in 2023
21
Germany's clinical lab services market size was €15.3 billion in 2022
22
Global cytogenetic testing market valued at $1.8 billion in 2023
23
U.K. pathology labs market generated £5.6 billion in 2023
24
France's medical biology labs market was €12.1 billion in 2023
25
Italy's clinical analysis market size reached €8.9 billion in 2022
26
Spain's lab testing services market was €4.7 billion in 2023
27
Mexico's clinical labs industry revenue hit MXN 120 billion in 2023
28
Global NGS-based lab testing market valued at $4.6 billion in 2023
29
U.S. esoteric testing market size was $28.4 billion in 2023
30
The worldwide urinalysis market stood at $1.4 billion in 2022 for lab use
Interpretation
Market Size Interpretation
The market size data shows strong and steady expansion with the global clinical laboratory services sector at USD 250.92 billion in 2022 projected to grow at a 5.8% CAGR alongside sizable regional footprints like the US at $92.4 billion in 2023 and Europe’s in vitro diagnostics at €28.5 billion in 2022.
More related reading
04 · Category
Regional Analysis29 stats
01
U.S. accounts for 40% of global clinical lab services market in 2023
02
North America held 38.5% share of IVD market worldwide in 2022
03
Europe represented 28% of global pathology services market in 2023
04
Asia-Pacific expected to grow fastest at 7.2% CAGR in lab testing to 2030
05
U.S. clinical labs performed 70% of Medicare diagnostic tests in 2023
06
China captured 22% of global molecular diagnostics market in 2023
07
Germany led EU with 25% of Europe's clinical lab revenue in 2022
08
India’s lab testing penetration at 15% of population in urban areas 2023
09
Brazil held 12% of Latin America clinical lab market share in 2023
10
Japan accounted for 18% of Asia-Pacific IVD market in 2023
11
U.K. represented 15% of European anatomic pathology market 2023
12
Canada’s clinical labs served 90% population coverage in 2023
13
South Korea held 10% of global NGS lab testing market 2023
14
Australia dominated Oceania lab testing with 85% market consolidation 2023
15
France captured 20% of Western Europe lab services in 2023
16
Mexico led Central America with 35% clinical lab market share 2023
17
Middle East lab testing market grew 9.5% in Saudi Arabia 2023
18
Italy held 12% of Southern Europe diagnostics market 2023
19
Spain accounted for 10% Iberian lab testing revenue 2023
20
Africa’s South Africa represented 40% of continent's lab market 2023
21
Russia’s clinical labs grew 6.8% despite sanctions in 2023 CIS region
22
Turkey captured 25% of Middle East IVD imports in 2023
23
Singapore led SEA lab testing hub with 30% regional share 2023
24
Argentina held 28% South American pathology market 2023
25
UAE’s Dubai labs processed 50% of Gulf diagnostics in 2023
26
Poland represented 8% Central Europe lab market growth leader 2023
27
North America’s lab testing volume hit 14 billion tests annually in 2023
28
Asia-Pacific performed 45% of world’s routine blood tests in 2023
29
Latin America’s lab density at 1.2 labs per 10,000 people in 2023
Interpretation
Regional Analysis Interpretation
For the Regional Analysis angle, North America is poised to remain the center of gravity with the U.S. alone accounting for 40% of global clinical lab services in 2023 and North America holding a 38.5% share of the worldwide IVD market in 2022, while Asia Pacific is the clear growth outlier expected to expand at a 7.2% CAGR in lab testing through 2030.
05 · Category
Technological Advancements28 stats
01
NGS adoption in labs increased by 45% from 2020 to 2023 globally
02
AI integration in lab diagnostics improved accuracy by 30% in 2023 studies
03
Digital pathology systems grew 18% in installations worldwide 2023
04
Lab-on-a-chip tech reduced testing time by 70% for POCT in 2023
05
CRISPR-based diagnostics entered 15% of molecular labs by 2023
06
Robotic automation handled 60% of routine lab workflows in top U.S. labs 2023
07
Cloud-based LIMS adoption rose 25% in clinical labs globally 2023
08
Mass spectrometry advancements boosted proteomics testing by 40% in 2023
09
Single-cell sequencing tech used in 20% of research labs by 2023
10
Blockchain for lab data security implemented in 12% of EU labs 2023
11
5G-enabled remote lab monitoring adopted by 8% global labs in 2023
12
Multiplex PCR assays increased throughput by 50% in infectious disease labs 2023
13
Wearable-integrated lab testing data analyzed in 15% U.S. labs 2023
14
Quantum dot tech enhanced immunoassay sensitivity 35% in 2023 labs
15
3D bioprinting for tissue pathology testing in 5% advanced labs 2023
16
Federated learning AI models trained across 10% networked labs 2023
17
Hyperspectral imaging adopted in 18% digital pathology labs 2023
18
Nanotech biosensors reduced detection limits 100-fold in 2023 POCT labs
19
Voice-activated lab informatics systems in 7% high-tech labs 2023
20
Metagenomics sequencing surged 55% in microbiome lab testing 2023
21
AR/VR for lab training used in 22% training programs 2023
22
Edge computing processed 40% real-time lab data on-site 2023
23
Organ-on-chip models replaced 30% animal testing in pharma labs 2023
24
Droplet digital PCR precision improved 25% in genetic labs 2023
25
Raman spectroscopy for non-invasive blood analysis in 9% labs 2023
26
IoT sensors monitored 35% lab equipment remotely in 2023
27
Spatial transcriptomics tech launched in 14% oncology labs 2023
28
HLA typing via NGS standardized in 28% transplant labs 2023
Interpretation
Technological Advancements Interpretation
Under technological advancements, labs are rapidly modernizing as shown by 45% global NGS adoption growth from 2020 to 2023 and a shift toward faster and smarter workflows with lab-on-a-chip cutting POCT testing time by 70% in 2023.
report visual · Key figures
Lab Testing Industry Statistics — Growth Rates (CAGR)
Key segments and regions are projected to grow at high single-digit to double-digit CAGRs, led by faster-growth markets such as India and NGS testing.
15%
India's lab testing market projected to grow 15% annually to 2028
15.4%
Global NGS lab testing projected 15.4% CAGR to 2030
12%
China's clinical testing sector expected 12% CAGR to 2030
10.5%
Mexico's clinical labs to grow 10.5% CAGR to 2030
7.1%
Global pathology services market to grow at 7.1% CAGR to 2030
8.3%
Brazil's clinical labs market to grow 8.3% annually to 2027
report visual · Key figures
Key Players by Market Share (Selected Markets, 2022–2023)
Selected leading lab testing players hold prominent shares across major regional and specialty markets.
25%
Quest Diagnostics held 25% market share in U.S. clinical lab testing in 2023
22%
LabCorp (Laboratory Corporation of America) commanded 22% U.S. market share in 2023 diagnostics
35%
Sonic Healthcare dominated 35% of Australia's pathology market in 2023
15%
Synlab Group led Europe's clinical lab services with 15% share in 2022
25%
Thyrocare dominated 25% of India's organized lab testing market in 2023
report visual · Comparison
Lab Testing Market Size (Global & Key Regions)
Major clinical lab testing markets vary widely across regions, with the global market substantially larger than individual national segments.
In the United States, the clinical laboratories industry generated revenue of $92.4 billion in 2023$92.4 billion
The U.S. diagnostic labs sector had a market size of $85.6 billion as of 2023
$85.6 billion
Europe's in vitro diagnostics market reached €28.5 billion in 2022
€28.5 billion
The global clinical laboratory services market was valued at USD 250.92 billion in 2022 and is projected to grow at a CA
5.8%
report visual · Breakdown
Regional market footprint in clinical lab testing (selected shares)
U.S. and North America dominate key global clinical lab/IVD shares, while Europe and Asia-Pacific represent substantial regional stakes.
70%
U.S. clinical labs performed 70% of Medicare diagnostic tests in 2023
30%
Singapore led SEA lab testing hub with 30% regional share 2023
report visual · Comparison
Technological Advancements Transform Lab Workflows
Key innovations—from AI and automation to cloud LIMS and next-gen sequencing—are rapidly increasing adoption across labs worldwide.
Lab-on-a-chip tech reduced testing time by 70% for POCT in 202370%
Robotic automation handled 60% of routine lab workflows in top U.S. labs 202360%
AI integration in lab diagnostics improved accuracy by 30% in 2023 studies30%
HLA typing via NGS standardized in 28% transplant labs 202328%
Cloud-based LIMS adoption rose 25% in clinical labs globally 202325%
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Stefan Wendt. (2026, February 13). Lab Testing Industry Statistics. Gitnux. https://gitnux.org/lab-testing-industry-statistics
MLA
Stefan Wendt. "Lab Testing Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/lab-testing-industry-statistics.
Chicago
Stefan Wendt. 2026. "Lab Testing Industry Statistics." Gitnux. https://gitnux.org/lab-testing-industry-statistics.
Sources & references
43 datasets cited across this report · attribution is report-level